Biotech Losers: China Biologic Products (NASDAQ:CBPO), Heat Biologics (NASDAQ:HTBX), Recro Pharma Inc (NASDAQ:REPH), Egalet Corp (NASDAQ:EGLT)

China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its financial results for the fourth quarter and fiscal year 2013. China Biologic Products Inc (NASDAQ:CBPO) stock performance was -6.25% in last session and finished the day at $32.85. Traded volume was 32,311.00million shares in the last session and the average volume of the stock remained 21.68K shares. … Continue reading Biotech Losers: China Biologic Products (NASDAQ:CBPO), Heat Biologics (NASDAQ:HTBX), Recro Pharma Inc (NASDAQ:REPH), Egalet Corp (NASDAQ:EGLT)

Biotech Unusual Volume: Evogene (NYSE:EVGN), Heat Biologics Inc (NASDAQ:HTBX), Alseres Pharmaceuticals (OTCMKTS:ALSE), EntreMed (NASDAQ:ENMD)

Evogene Ltd. (NYSE:EVGN)(TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today its financial results for the fourth quarter and year ended December 31, 2013. Evogene Ltd (NYSE:EVGN) stock performance was 2.35% in last session and finished the day at $19.56. Traded volume was 54,493 million shares in the last session and the average volume … Continue reading Biotech Unusual Volume: Evogene (NYSE:EVGN), Heat Biologics Inc (NASDAQ:HTBX), Alseres Pharmaceuticals (OTCMKTS:ALSE), EntreMed (NASDAQ:ENMD)